- How many patients have been treated (for any condition) in the last 4 months with:
- Benralizumab 0
- Dupilumab <7
- Omalizumab <7
- Reslizumab 0
- Mepolizumab <7
- Tezepelumab 0
- Of the patients treated in the last 4 months with any of the above products, please provide the number of patients by the following age-groups:
- Age 6-11 0
- Age 12-17 <7
- Age 18 and above 12
- How many patients have been treated in the last 4 months by the Respiratory Medicine department ONLY with:
- Dupilumab <7
- Omalizumab <7
Where we have given <7 answers this is because NHS Shetland considers that providing more specific detail carries a high risk of identifying individuals. As such and in accordance with FOISA s 16(1), NHS Shetland confirms that it holds the information requested but that it is exempt from disclosure under FOISA s 38(1)(b) as read with s 38 (2A) as the information constitutes personal data and disclosure would breach the confidentiality of the data subjects.
